prof. Charles Van Praet (MD, PhD)

CRIG member
Charles Van Praet


Urologist - UZ Gent
Associate Professor - Faculty of Medicine and Health Sciences, UGent
Principal investigator: prof. Nicolaas Lumen (MD, PhD)

 

Research focus

Our overall goal is to improve diagnostics and treatments in urologic cancers.

Kidney cancer:
Better operative planning through use of digital 3D models with kidney perfusion for robot-assisted partial nephrectomy. Principal Investigator of the PODRACING trial: “Planning Operative strategy using a Digital Renal Artery ClampING tool”.

Bladder cancer:
Prevention and management of parastomal hernia in patients with an ileal conduit. Principal Investigator of the PAPRICA-1 trial: “PArastomal hernia Prevention in Robot cystectomy with Ileal Conduit: A pilot study”. 
 

Biography

Charles is an oncologic urologic surgeon at UZ Gent, performing mainly robotic surgery.

He graduated as a medical doctor in 2012 at Ghent University and received his training in Urologic surgery at OLV Waregem, AZ Sint-Lucas Gent and UZ Gent. 

In 2017, Charles presented his PhD thesis under the supervision of Prof. Nicolaas Lumen on “Evaluation of novel treatments in prostate cancer: concerning innovations in the field of minimal-invasive surgery, whole-pelvis radiotherapy and hormonal therapy with abiraterone acetate”.

In 2019, he finished his training in Urology, started working at UZ Gent and became a fellow of the European Board of Urology. In 2022, he was appointed as Professor in Urologic Oncology at Ghent University. In 2023, together with Prof. Karel Decaestecker, he received a grant from Stichting Tegen Kanker to perform the PODRACING trial for better kidney sparing during robotic partial nephrectomy.
 

Research team

Key publications

  • A Novel Three-dimensional Planning Tool for Selective Clamping During Partial Nephrectomy: Validation of a Perfusion Zone Algorithm. Eur Urol 2023;83(5): 413-421.
  • Improving Augmented Reality Through Deep Learning: Real-time Instrument Delineation in Robotic Renal Surgery. Eur Urol. 2023;84(1): 86-91.
  • Robot-assisted Partial Nephrectomy Using Intra-arterial Renal Hypothermia for Highly Complex Endophytic or Hilar Tumors: Case Series and Description of Surgical Technique. Eur Urol Open Sci 2023;58:19-27.
  • Current role of cytoreductive nephrectomy in metastatic renal cell carcinoma. Turk J Urol 2020; 47: S79-S84
  • Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program. Urol Oncol 2016;34(6):254e7-e13.
     

Contact & links